
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
(Image credit: Eva Marie Uzctegui/Bloomberg via Getty Images)

Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
(Image credit: Eva Marie Uzctegui/Bloomberg via Getty Images)
Click to the ad
0 comments:
Post a Comment